Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
about
Identifying prognostic features by bottom-up approach and correlating to drug repositioningPeroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway.Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer.Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cellsThyroid-specific transcription factors and their roles in thyroid cancer.Peroxisome proliferator-activated receptors and cancer: challenges and opportunitiesPigment epithelium-derived factor (PEDF) promotes tumor cell death by inducing macrophage membrane tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).PPARγ Promotes Growth and Invasion of Thyroid Cancer CellsPPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma.Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinomaPeroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma.Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.PPARs and Mitochondrial Metabolism: From NAFLD to HCC.MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.Dietary restriction protects against diethylnitrosamine-induced hepatocellular tumorigenesis by restoring the disturbed gene expression profile.Functional role of peroxisome-proliferator-activated receptor γ in hepatocellular carcinoma.Mouse models for liver cancer.Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer.CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.Hepatitis D and hepatocellular carcinoma.Adenoviral gene therapy in hepatocellular carcinoma: a review.The role of thiazolidinediones in hepatocellular carcinoma risk reduction: a population-based cohort study in Taiwan.Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma.Peroxisome proliferator-activated receptor-γ activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1.Establishment of a cell-based drug screening model for identifying agonists of human peroxisome proliferator-activated receptor gamma (PPARγ).Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway.MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.Hepatocyte nuclear factor 1α suppresses steatosis-associated liver cancer by inhibiting PPARγ transcription.PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma.Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice.Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulationPPARs Signaling and Cancer in the Gastrointestinal System.Species-specific differences in peroxisome proliferation, catalase, and SOD2 upregulation as well as toxicity in human, mouse, and rat hepatoma cells induced by the explosive and environmental pollutant 2,4,6-trinitrotoluene.Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.Pharmacologic Inhibition of the Menin-MLL Interaction Leads to Transcriptional Repression of PEG10 and Blocks Hepatocellular Carcinoma.Regulation of the tumor suppressor PTEN by natural anticancer compounds.Activation of peroxisome proliferator-activated receptor-gamma inhibits tumor growth by negatively regulating nuclear factor-κB activation in patients with hepatocellular carcinoma.
P2860
Q28543844-19190C11-8731-4E7F-B06F-D80A555D61F8Q34483561-0C2C61FC-156D-4F9B-8CDB-9F49C97ACB9CQ34646050-DC38C281-43B5-41BB-912E-435CC606F901Q34983695-B24A7018-7C8C-48AB-BA92-1873F2E26E3FQ35038884-4CCD8794-8BCC-4B5B-98F2-88D5FAB29B3CQ35210023-5CF53228-7CFF-4BD2-928C-1D57C93CDD8EQ35371579-63C69E01-87BF-41A0-8C7A-A30409588FC1Q35608757-39237D00-B785-4391-B015-D670214E814BQ35927161-B444B524-A6F9-44D1-9E33-54B3038D0B3FQ36253614-6AFE2775-A709-424C-826F-FD68D1E26E3EQ36385805-27756A12-BB4E-4456-984B-5B3F7E4E0720Q37031730-0CF502CB-AA9D-401B-BBA8-2D7B9CA78D6DQ37209921-63F0D84C-7A83-40A4-ABB5-AC149A80E928Q37497314-2430AC7C-813D-4E75-ACE1-5C59A1AD1387Q37575571-29017CFF-7DC0-4309-A6A4-7FD75C22E832Q37607478-9C7EB908-FCEC-4698-8AC2-935F876C6F4DQ37682244-D9F944E6-C38C-4972-ABBD-40A003FA2350Q38022356-96E184D8-DD2D-476A-94C3-8B026CC4D71CQ38083387-3795DA95-6856-43F8-A9B3-29125880E142Q38161361-AE567B34-138B-46AD-A363-450FC4CA9C6FQ38319523-AA9B1C1D-411A-41D1-9F3E-046BA64DC7D1Q38443653-A9751BE2-5C5D-46A2-A614-B881A390DD5FQ38552204-0A469826-0AF6-4B93-BF5B-0087EDDEC3C9Q38661239-97C82360-23F7-4190-BD92-D8DED9F704CFQ39156798-C2B52B24-F0B3-488B-B23F-C59D47A392C9Q39185282-1A36F394-D687-49B9-992C-3997F3FD14F6Q39370163-87326479-5CAF-4213-A3C3-85CD545E8236Q39592722-5803CA2B-B93F-48FA-9067-095D7FEA61DBQ40254590-DCBC605A-D3E6-4823-A642-99CDBFFF9EF2Q42036894-FE7C5986-FEED-4A43-8865-0126E0E14365Q42125206-7F5E1442-ABFD-40AB-A57D-40D3397080BCQ42513537-73D5F311-EA33-476E-B5DB-B4BF48F03444Q42580571-ED1F4EAC-F6C5-4CC1-82D0-9B2D89968377Q42641213-FC3FB5F7-60A6-4DA8-B7C8-9185BB6F63EBQ42695741-37782682-B3DC-413C-8B0E-E2ECD0A12AB1Q45280727-C51A05E6-4263-4DB1-A119-9C902326BA99Q47144193-D195A47C-6ACC-472B-B30F-12768883551CQ47398654-2D10D608-21E2-4CDB-804E-588B99EC25A3Q47691876-D745B152-AF8D-4EF9-9996-0499CAED616EQ51620910-B1677ECB-D24A-489E-B1EB-B6C597CDE1CA
P2860
Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Inhibitory role of peroxisome ...... ogenesis in mice and in vitro.
@en
Inhibitory role of peroxisome ...... ogenesis in mice and in vitro.
@nl
type
label
Inhibitory role of peroxisome ...... ogenesis in mice and in vitro.
@en
Inhibitory role of peroxisome ...... ogenesis in mice and in vitro.
@nl
prefLabel
Inhibitory role of peroxisome ...... ogenesis in mice and in vitro.
@en
Inhibitory role of peroxisome ...... ogenesis in mice and in vitro.
@nl
P2093
P2860
P356
P1433
P1476
Inhibitory role of peroxisome ...... nogenesis in mice and in vitro
@en
P2093
Chung-Wah Wu
Cleo N Y Lam
Eagle S H Chu
Henry L Y Chan
Junhong Zhao
Kin-Fai Cheung
P2860
P304
P356
10.1002/HEP.23550
P407
P577
2010-06-01T00:00:00Z